At the molecular level, we identified a set of overlapping genes functionally enriched in inflammation, metabolism, and neurological signaling pathways—four of which (CYP2C19, NLRP3, PVT1, and APP) form a core regulatory network potentially mediating the impact of DM on HNSCC development. This evidence concerns the gene CYP2C19 and head and neck squamous cell carcinoma.